Zogenix Performance
The firm maintains a market beta of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Zogenix are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Zogenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Zogenix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 4.49 | |
| Fifty Two Week Low | 11.03 | |
| Target High Price | 62.00 | |
| Fifty Two Week High | 26.90 | |
| Target Low Price | 17.00 |
Zogenix |
Zogenix Relative Risk vs. Return Landscape
If you would invest (100.00) in Zogenix on January 24, 2024 and sell it today you would earn a total of 100.00 from holding Zogenix or generate -100.0% return on investment over 90 days. Zogenix is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Zogenix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zogenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zogenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zogenix, and traders can use it to determine the average amount a Zogenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ZGNX |
Based on monthly moving average Zogenix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zogenix by adding Zogenix to a well-diversified portfolio.
Zogenix Fundamentals Growth
Zogenix Stock prices reflect investors' perceptions of the future prospects and financial health of Zogenix, and Zogenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zogenix Stock performance.
| Return On Equity | -75.09 | |||
| Return On Asset | -22.99 | |||
| Operating Margin | (343.93) % | |||
| Current Valuation | 760.86 M | |||
| Shares Outstanding | 55.99 M | |||
| Price To Earning | (11.28) X | |||
| Price To Book | 6.65 X | |||
| Price To Sales | 23.49 X | |||
| Revenue | 63.58 M | |||
| EBITDA | (209.23 M) | |||
| Cash And Equivalents | 343.02 M | |||
| Cash Per Share | 6.13 X | |||
| Total Debt | 166.58 M | |||
| Debt To Equity | 0.74 % | |||
| Book Value Per Share | 4.01 X | |||
| Cash Flow From Operations | (182.32 M) | |||
| Earnings Per Share | (4.35) X | |||
| Total Asset | 305.82 M | |||
| Retained Earnings | (465.94 M) | |||
| Current Asset | 184.5 M | |||
| Current Liabilities | 29.99 M | |||
Things to note about Zogenix performance evaluation
Checking the ongoing alerts about Zogenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zogenix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zogenix is not yet fully synchronised with the market data | |
| Zogenix has some characteristics of a very speculative penny stock | |
| Zogenix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 63.58 M. Net Loss for the year was (242.7 M) with loss before overhead, payroll, taxes, and interest of (124.9 M). | |
| Zogenix currently holds about 343.02 M in cash with (182.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.13. | |
| Over 99.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Zogenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zogenix's stock is overvalued or undervalued compared to its peers.
- Examining Zogenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zogenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zogenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zogenix's stock. These opinions can provide insight into Zogenix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Zogenix Stock
If you are still planning to invest in Zogenix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zogenix's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |